Who is a Candidate?

If a patient is experiencing limited mobility or severe muscle weakness due to a stroke injury, he or she may be a candidate for the Myomo e100 NeuroRobotic System.

The Myomo e100 NeuroRobotic System is initially indicated for individuals who have upper extremity hemiparesis/hemiplegia (loss of voluntary motor control or severe arm weakness) as a result of a stroke. The device is only available by a prescription from a physician or physical therapist, and is intended for clinical use by patients with their treating therapist.

There are specific contraindications that preclude an individual from using the Myomo e100 NeuroRobotic System, including: persons who have a rigid contracture in the upper arm or who have a recent history of muscle spasms. Persons who have no EMG signal are also not appropriate candidates for the Myomo e100 NeuroRobotic System.

A complete list of all contraindications is available in the Myomo e100 NeuroRobotic System User Manual. To learn more contact us.

Note: Federal (USA) law restricts this device to sale by or on the order of a physician or physical therapist.

Note: The Myomo e100 NeuroRobotic System is intended for clinical use by patients with their treating medical professional. The device has not been shown to be safe or effective as a functional aid for use in the home.